Fact CheckerSign in

NCT02956239Completed

Development, Field Testing and Evaluation of the Efficacy of a Hand-held, Portable and Affordable Thermo-coagulator to Prevent Cervical Cancer in Low- and Middle-income Countries

Source: ClinicalTrials.gov · Last updated 8 Jul 2024

Brief summary (registry, in English)

This project develops, tests and produces a lightweight, cordless, battery driven and rechargeable hand-held device for treating cervical precancer (Liger Thermal Coagulator). The study evaluates its effectiveness compared to the current standard treatment (cryocautery) when used as part of a screen and treat programme using Visual Inspection with Acetic acid (VIA) in Sub Saharan Africa.

Status (registry)
Completed
Study type
Interventional
Enrollment
3124 (actual)
First submitted
6 Sept 2016
Start date
1 Aug 2017
Primary completion date
16 Feb 2022
Lead sponsor
International Agency for Research on Cancer
NCT number
NCT02956239

What you commit to

  • Study type: Interventional
  • Participants enrolled: 3124
  • From 1 Aug 2017 to the primary completion date, 16 Feb 2022
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Pregnancy
  • Not voluntarily willing to participate

Who the study is looking for

  • Positive on VIA test for cervical cancer screening
  • Eligible for ablative treatment

Age in the registry: 25 years to 49 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
UNC Global Project Zambia
Coordinator of this site? Confirm its status
LusakaZambiaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.